These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Features of macrovascular complications in type 2 diabetic patients. Strojek K Acta Diabetol; 2003 Dec; 40 Suppl 2():S334-7. PubMed ID: 14704864 [TBL] [Abstract][Full Text] [Related]
7. Prevention of coronary heart disease in type 2 diabetes. Mykkänen L Int J Clin Pract Suppl; 2000 Oct; (113):40-5. PubMed ID: 11965831 [TBL] [Abstract][Full Text] [Related]
8. Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes. Mazzone T J Lab Clin Med; 2000 Jun; 135(6):437-43. PubMed ID: 10850642 [No Abstract] [Full Text] [Related]
9. The relationship between lipoprotein(a) and the complications of diabetes mellitus. Koschinsky ML; Marcovina SM Acta Diabetol; 2003 Jun; 40(2):65-76. PubMed ID: 12861403 [TBL] [Abstract][Full Text] [Related]
11. Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. von Bibra H; Hansen A; Dounis V; Bystedt T; Malmberg K; Rydén L Heart; 2004 Dec; 90(12):1483-4. PubMed ID: 15547039 [No Abstract] [Full Text] [Related]
12. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes]. Hemmingsen B; Lund SS; Vaag A Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642 [TBL] [Abstract][Full Text] [Related]
13. [Control of atherosclerosis in diabetes mellitus]. Quiroz Martínez A Arch Cardiol Mex; 2003; 73 Suppl 1():S125-7. PubMed ID: 12966662 [TBL] [Abstract][Full Text] [Related]
14. [Diabetes and atherosclerosis. Physiopathology of diabetic macroangiopathy]. Leutenegger M Rev Med Interne; 1994; 15 Suppl 3():270S-273S. PubMed ID: 7863131 [No Abstract] [Full Text] [Related]
15. Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents. Dandona P; Aljada A J Diabetes Complications; 2004; 18(2):91-102. PubMed ID: 15120703 [TBL] [Abstract][Full Text] [Related]
16. Post-prandial hyperglycaemia and vascular disease. Hanefeld M Int J Clin Pract Suppl; 2000 Sep; (112):13-8. PubMed ID: 11064946 [No Abstract] [Full Text] [Related]
17. New advances in the management of insulin resistance in type 2 diabetes. Introduction. Campbell IW; Charbonnel B Int J Clin Pract Suppl; 2001 Sep; (121):3. PubMed ID: 11594242 [No Abstract] [Full Text] [Related]
18. [Prevention of arteriosclerosis with the insulin sensitizer pioglitazone. Early intervention in diabetic patients compensates "cell ignorance"]. MMW Fortschr Med; 2002 May; 144(21):52-3. PubMed ID: 12134427 [No Abstract] [Full Text] [Related]
19. [Physiopathology of atherosclerosis in diabetics]. Tedgui A Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 3():13-6. PubMed ID: 15666476 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of insulin sensitizers in diabetes. Jawa A; Fonseca V Curr Opin Investig Drugs; 2006 Sep; 7(9):806-14. PubMed ID: 17002258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]